Q&A Confirming Next-Gen Sequencing Results with Sanger

Oct 11, 2016, 15:19 PM by Michael Croft

The Scientist | Ambry Genetics CEO Aaron Elliott discusses his team's recent analysis of 20,000 clinical next-generation sequencing panels.

October 11, 2016 | Ambry Genetics CEO Aaron Elliott discusses his team's recent analysis of 20,000 clinical next-generation sequencing panels. The Scientist